Reprogramming Chronic Care: AI-Driven Digital Therapeutics for a Connected, Personalized and Equitable Health Future
No Thumbnail Available
Date
2025-10-20
Authors
Soumarshi Das
Ravinder Singh
Journal Title
Journal ISSN
Volume Title
Publisher
Chitkara University Publications
Abstract
Background: Non-communicable diseases such as diabetes, cardiovascular disease, and mental disorders contribute to 74% of global annual deaths, creating a major strain on healthcare systems. Conventional episodic care models are inadequate for continuous management, highlighting the need for innovative solutions.
Purpose: This review systematically evaluates the role of AI-powered Digital Therapeutics (DTx) in chronic disease management, examining clinical evidence, therapeutic outcomes, regulatory frameworks, and future integration with multidisciplinary healthcare systems, with a focus on low- and middle-income settings such as India.
Methods: A comprehensive literature search of clinical trials, meta-analyses, and real-world studies was conducted. Regulatory frameworks like the FDA’s Software as a Medical Device (SaMD) and India’s Ayushman Bharat Digital Mission (ABDM) were analyzed to assess the positioning of Digital Therapeutics (DTx) in healthcare systems.
Results: Digital therapeutics (DTx) showed significant advantages in chronic disease management: HbA1c reduction of 0.67% in Type 2 Diabetes patients, improved hypertension control with 84% of patients maintaining sustained blood pressure control over three years, and PHQ-9 score reductions by 7.3 points in depression. The AI-driven DTx platform provided real-time adaptive interventions using digital biomarkers and phenotyping. Despite these outcomes, widespread adoption faces challenges from low digital literacy, regulatory uncertainty, and inadequate reimbursement structures, especially in India.
Conclusion: AI-powered Digital Therapeutics (DTx) offer transformative solutions for chronic disease management by enabling personalized, adaptive care. Integrating DTx with Electronic Health Records (EHRs) enhances clinical decision-making and preventive care, but implementation is hampered by regulatory fragmentation and technological gaps.
Description
Keywords
Digital therapeutics (DTx), Chronic disease management, Artificial intelligence (AI) in healthcare, Personalized medicine, Digital phenotyping